Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-02-26 |
Court | District Court, D. New Jersey | Date Terminated | 2019-05-02 |
Cause | 28:1338 Patent Infringement | Assigned To | Peter G. Sheridan |
Jury Demand | None | Referred To | Douglas E. Arpert |
Patents | 7,943,582; 8,513,202 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED
Details for MITSUBISHI TANABE PHARMA CORPORATION v. LUPIN LIMITED (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | 1 | United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively… Infringement of U.S. Patent No. 7,943,582 43. Plaintiffs repeat…collectively, the “Patents-in- suit”) under the patent laws of the United States, 35 U.S.C. §100, et seq. This… THE PATENTS-IN-SUIT 11. On May 17, 2011, the United States Patent and Trademark… the ’582 patent. 13. JNV is an exclusive sublicensee of the ’582 patent. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |